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Total Synthesis
An Alkyne-Metathesis-Based Approach to the Synthesis of the Anti-
Malarial Macrodiolide Samroiyotmycin A
Ektoras Yiannakas, Mark I. Grimes, James T. Whitelegge, Alois Frstner, and Alison N. Hulme*
Abstract: We report the first total synthesis of samroiyotmy-
cin A (1), a C2-symmetric 20-membered anti-malarial macro-
diolide isolated from Streptomyces sp. The convergent syn-
thetic strategy orchestrates bisalkyne fragment-assembly using
an unprecedented Schçllkopf-type condensation on a substi-
tuted b-lactone and an ambitious late-stage one-pot alkyne
cross metathesis–ring-closing metathesis (ACM–RCAM) reac-
tion. The demanding alkyne metathesis sequence is achieved
using the latest generation of molybdenum alkylidynes
endowed with a tripodal silanolate ligand framework. Subse-
quent conversion to the required E-alkenes uses contemporary
hydrometallation chemistry catalysed by tetrameric cluster
[{Cp*RuCl}4].
In 2013, Pittayakhajonwut and co-workers reported that the
crude extracts of Streptomyces sp. BCC33756 exhibited potent
activity against a multi-drug resistant (MDR) malarial
strain.[1] A C2-symmetric macrodiolide from this extract,
samroiyotmycin A (1), was shown to be active against both
the MDR malarial strain P. falciparum K1 (IC50:
3.65 mgmL1) and lung carcinoma cell line NCI-H187 (IC50:
24.14 mgmL1).[1] We envisaged rapid access to this promising
scaffold using a one-pot alkyne cross metathesis–ring-closing
alkyne metathesis (ACM–RCAM) approach. Our previous
work on the macrodiolide disorazole C1
[2] suggested this
would allow rapid construction of the macrodiolide core
with control over both the orientation of subunits and ring
size.
A priori, the initial disconnection for this ACM–RCAM
approach can be implemented across either the E-configured
C(5)C(6)/C(21)C(22) di-substituted alkenes, or the C(3)
C(4)/C(19)C(20) E-enoates (black and grey routes, respec-
tively, Scheme 1 (i)). Comparing end-games: in the former
strategy, conversion of bis(enyne) 2 to the E-configured
alkenes in the absence of protic groups proximal to the
acetylene is likely to be challenging;[3–5] whilst in the second
strategy, conversion of bis(ynoate) precursor 3 to samroiyot-
mycin A via ynoate–dienoate isomerisation,[6–13] bisiodina-
tion,[14] and double Stille/Negishi coupling[15, 16] has better
precedent. Examining the ACM–RCAM step, although both
ACM and RCAM reactions of ynoates have been explored in
isolation previously, the number of successful examples is
small,[17–23] likely because electron-deficient triple bonds in
general are poorly reactive and ynoates in particular were
beyond reach of the classical catalysts.[24, 25] To our knowledge
there are no examples of a one-pot ynoate ACM–RCAM, as
Scheme 1. Convergent one-pot ACM–RCAM approaches to samroiyot-
mycin A. (i) Ring deconstruction via routes based on C(5)C(6)/C-
(21)C(22) or C(3)C(4)/C(19)C(20) disconnections to key inter-
mediate 6 ; (ii) Installation of C(9)/C(10) and C25)/C(26) stereochem-
istry via cyclocondensation onto a-chiral aldehyde 9.[*] E. Yiannakas, M. I. Grimes, J. T. Whitelegge, Prof. A. N. Hulme
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required for the assembly of the 20-membered core of
samroiyotmycin A (1). With this in mind, we devised a unified
strategy for construction of the bisalkyne building blocks,
which would allow us to explore both routes. This strategy
centred on desulfonylation of 5-substituted 4-tosyloxazoles 7
and esterification of the resultant secondary alcohols 6 to give
bisalkyne fragments 4 and 5. Influenced by prior work,[26] we
hypothesised that formation of linchpin fragments 7
(Scheme 1 (ii)) could be achieved through a Schçllkopf-type
condensation of 4-substituted b-lactones 8 with anionic
TosMIC.[27–29] If successful, this ambitious strategy would
allow simultaneous installation of the 1,3-oxazole unit and
stereochemistry at C(10). Furthermore, we envisaged that
construction of the diastereomerically pure b-lactones 8
would be possible via an asymmetric ketene cycloaddition
to a-methyl aldehydes 9.[30] Our synthetic approach to
exploring these two proposed one-pot ACM–RCAM strat-
egies is outlined below.
To explore our novel synthetic approach to setting the
C(9)C(10) stereochemistry required generation of a-chiral
aldehydes 9a/b. Our initial approach focused on the diaste-
reoselective alkylation of N-acylated oxazolidinones
(Scheme 2 (i)). Due to competing elimination reactions
observed when alkylating the propionate derivative, diaste-
reoselective methylation of the oxazolidinone derivatives
10a/b (see SI for preparation) was the preferred route. This
reaction delivered the N-acyl derivatives 11a/b on a multi-
gram scale in good to excellent yield (77–98%) and with high
selectivity (> 20:1 dr).[31] Hydrolytic cleavage of the chiral
auxiliary in the presence of H2O2 gave the corresponding
acids 12 a/b in almost quantitative yield (95%). Conversion to
the configurationally stable Weinreb amides 13a/b was
accompanied by a very slight erosion of enantiomeric purity,
as observed by HPLC on a chiral stationary phase. DIBAL-H
reduction (Scheme 3 (i)) provided the sensitive a-methyl
aldehydes 9a/b, primed for chain elongation by an acetate
aldol equivalent.[32] The asymmetric ketene–aldehyde cyclo-
addition catalysed by the Lewis base O-TMS quinine 14 was
chosen for this purpose due to high levels of stereochemical
control exerted by this cinchona alkaloid catalyst in intra-
molecular nucleophile-catalysed aldol lactonisation (NCAL)
reactions of a- or b-substituted aldehyde acids,[33] and in
intermolecular NCAL reactions featuring aldehydes with
remote substitution.[34] This reaction converted crude alde-
hyde 9a into the thermally unstable b-lactone 8a with
excellent diastereocontrol over the newly formed stereo-
centre at C(10) (> 99:1 dr). To the best of our knowledge, this
is the first example of an intermolecular NCAL reaction with
double diastereodifferentiation, where the catalyst control
dominates over the influence of an a-chiral centre on the
aldehyde. Immediate low-temperature Schçllkopf-type con-
densation of 8a with anionic TosMIC furnished chiral alcohol
7a in excellent overall yield (35 % from oxazolidinone 11a,
following a five-step telescoped sequence) and with high
diastereoselectivity (96:4 dr). When repeated with the longer-
chain oxazolidinone 11b, the same five-step sequence yielded
alcohol 7b in 43 % overall yield (> 99:1 dr). In both cases, the
configuration at C(10)OH was confirmed by conversion to
Mosher esters 15 and 16 (see SI for details).
For the total synthesis of samroiyotmycin A, we stream-
lined our route by switching to the use of Myers acylated
pseudoephedrine auxiliary 17, since the amide formed upon
alkylation can be directly converted to the enantioenriched a-
methyl aldehyde (Scheme 2 (ii)). Diastereoselective alkyla-
tion of the lithium enolate of 17 using 5-iodopent-2-yne
afforded multigram quantities of amide 18 a in very good yield
(79 %, 75:1 dr). Reductive cleavage of the auxiliary using
LiAl(OEt)3H generated in situ at low temperature gave
aldehyde 9a,[35, 36] which was used directly in the cyclocon-
densation catalysed by O-TMS quinine 14 to afford b-lactone
8a (> 99:1 dr). Immediate condensation of crude 8a with
anionic TosMIC provided chiral alcohol 7a in excellent yield
(52 %, over a three-step telescoped sequence) and with high
Scheme 2. Setting C(9) stereochemistry via alkylation of an acylated
Evans’ oxazolidinone (i), or Myers’ pseudoephedrine (ii) auxiliary.
Reagents and Conditions: a) MeI, NaHMDS, THF, 78 8C, 4.5 h, (11 a,
77%, >20:1 dr; 11b, 98%, >20:1 dr); b) LiOH, H2O2, THF/H2O
(1:1), 0 8C!rt, (12a, 95 %, 93% ee ; 12 b, 94 % ee); c) CDI, HN-
(OMe)Me·HCl, CH2Cl2, 0 8C!rt, 18 h, (13a, 93% ee; 13b, 82% from
11b, 92% ee); d) LDA, LiCl, 5-iodopent-2-yne or 7-iodohept-2yne,
78!0 8C, 2 h, (18 a, 79 %, 75:1 dr; 18b, 98%, 71:1 dr); e) LiAlH4,
EtOAc, THF/isohexanes (4:3), 78 8C!0 8C, 1 h.
Scheme 3. Introduction of C(10)OH and 4-tosyloxazole functionalities.
Reagents and Conditions: a) DIBAL-H, CH2Cl2, 78 8C, 1 h; b) 14
(10 mol%), LiClO4, AcCl, DIPEA, CH2Cl2/Et2O (1:1–2:1), 78 8C, 18–
24 h, >99:1 dr; c) TosMIC, nBuLi, THF, 78 8C!rt, 1 h (7a, 35%,
96:4 from 11a, or 52 %, >97:3 dr from 18a ; 7b 43%, >20:1 dr from
11b, or 24%, >20:1 dr from 18 b); d) (S)-(+)-MTPACl, DMAP
(10 mol%), TEA, CH2Cl2, rt, 18 h, (15a, 77 %; 15b, 85 %), e) (R)-()-
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diastereoselectivity (97:3 dr) on multi-gram scale. 4-Tosylox-
azole 7b was also obtained by adaptation of this synthetic
route; asymmetric alkylation of the acylated auxiliary with 7-
iodohept-2-yne to give 18b, reduction to aldehyde 9b, and
elaboration to diastereomerically pure b-lactone 8b. Careful
optimisation of the cycloaddition reaction conditions showed
that use of an equivolume mixture of Et2O and CH2Cl2 as
solvent gave the highest conversion and diastereoselectivity
for this substrate. Subsequent condensation of the crude
lactone 8b with TosMIC delivered fragment 7b in good yield
(24 % over a three-step telescoped sequence) and similarly
high diastereoselectivity (> 99:1 dr).
A number of methods were initially evaluated for the
reductive desulfonylation of advanced intermediates 7a and
7b.[37–39] To our surprise, sonication of fragment 7a in THF/
EtOH with Na(Hg) amalgam delivered the fragile chiral
alcohol 6a, which was found to be prone to degradation even
on silica.[38] Gratifyingly, EDC-mediated esterification with
acid 19 (see SI for preparation) furnished the stable bisalkyne
4 and set the stage for the envisaged one-pot ACM–RCAM
reaction (Scheme 4). Our synthetic plan for bisalkyne 5 was to
follow this route via tosyl group removal to give 6b and
esterification with 2-butynoic acid 20. Unfortunately, sonica-
tion of both fragment 7b, or its TBS ether 21b, in THF/EtOH
with Na(Hg) amalgam (2.0–10.0 equiv, 10 mol% Na) either
failed completely, or led to instantaneous decomposition.
Even the use of SmI2 with DMPU, reported to be a partic-
ularly mild alternative,[39] only led to the recovery of starting
material. This unforeseen subtlety rendered the ynoate–yne
one-pot ACM–RCAM strategy non-viable and enforced an
adjustment to our final synthetic plan.
For our one-pot ACM–RCAM investigation, we
employed the two latest-generation molybdenum alkylidynes
(22 a/b) endowed with the privileged tripodal silanolate ligand
framework.[40, 41] Based on prior work from our group, we
treated a solution of bisalkyne 4 in toluene (50 mm) with
molybdenum alkylidyne complex 22a (10 mol %) at ambient
temperature in the presence of molecular sieves (5 ) to
scavenge the released 2-butyne.[2] Following the reaction by
reverse-phase LC–MS (l = 254 nm) indicated no conversion
even after four hours at room temperature. However, full
conversion to cyclobis(enyne) 2 was attained within two hours
by raising the temperature to 60 8C (Table 1, entry 1). Routine
chromatography gave the cross-dimer 2 in analytically pure
form in 53 % yield. Although no linear dimers, higher-order
oligomers, nor the corresponding homo-dimeric isomer were
discernible by LC–MS, we nonetheless suspected competing
concentration-induced polymerisation. This undesired path-
way, which seems to be independent of the initial catalyst
loading (Table 1, entry 2), can be effectively suppressed by
performing the reaction at a higher dilution. Indeed, treat-
ment of a more dilute solution of monomer 4 (30 mm) with
complex 22 a (20 mol %) gave a significantly improved yield
(Table 1, entry 3). Higher catalyst loading (Table 1, entry 4)
and further dilution (Table 1, entry 5) gave no additional
improvements. With complex 22b, full conversion to the
desired one-pot ACM–RCAM product 2 was only achieved
after overnight heating at 80 8C (Table 1, entry 6) and
isolation of the product was hindered by fragmentation of
the catalyst ligand. These results highlight the remarkable
functional group tolerance and robustness of catalyst 22 a,[40]
which activates even the most demanding triple bonds under
mild conditions in the presence of basic heterocycles. We
suggest that the rigidified backbone and greater steric











1[a] 10 60 50 2 53
2[a] 20 60 50 2 55
3[a] 20 60 30 1 74
4[a] 30 60 30 1 71
5[a] 30 60 15 3 71
6[b] 20 80 30 18 50
[a] Reaction conditions: catalyst: complex 22a, solvent: toluene, addi-
tive: 5  MS. [b] Reaction conditions: catalyst: complex 22b, solvent:
toluene, additive: 5  MS.
Scheme 4. Synthesis of bisalkyne building blocks and bisalkyne cyclic dimers. Reagents and Conditions: a) TBSOTf, 2,6-lutidine, CH2Cl2, 0 8C!rt,
18 h, 73% (17 b); b) Na(Hg) (10 mol% Na), Na2HPO4, THF/EtOH (1:1), 4 h; c) EDC·HCl, acid 19, DMAP (10 mol%), CH2Cl2, 0 8C!rt, 18 h,
70% over two steps (4); d) see Table 1.
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encumbrance of the coordination sphere of the podand
complex 22 b are responsible for its reduced reactivity,
particularly for electron-deficient substrates such as 1,3-
enynes, which are known to be less reactive.[41]
With the desired 20-membered macrocyclic framework in
hand, our two end game steps could be tackled. Inspired by
the recent formal synthesis of the lichen-derived macrolide
(+)-aspicilin,[18] we envisioned that trans-reduction of the
newly formed alkynes to the required E-configured alkenes
would be achieved via a bis(trans-hydrostannation–protodes-
tannation) sequence. However, these key steps bore substan-
tial risk, since electron-rich arenes and 1,3-enynes often act as
catalyst poisons in the trans-hydrostannation reaction.[42] This
stems from the ability of these substrates to bind to the
[Cp*Ru] fragment through kinetically stable h4 or
h6 complexation, halting further trans-hydrometallation of
the alkyne triple bond (A and B, Scheme 5 (i)).[43] Further-
more, neighbouring group coordination often facilitates both
the productive binding of the [Cp*Ru] and the selective
proximal delivery of SnBu3 to the triple bond (C and D,
Scheme 5 (ii)).[43] In the absence of directing groups, we
anticipated that a double hydrostannation reaction would
lead to a statistical mixture of proximal and distal stannylated
products (E, F and G, Scheme 5 (iii)), all of which derive from
a double trans-hydrometallation process and can effectively
deliver the desired E-configured alkenes upon protodestan-
nation. In practice, hydrostannation of bis(enyne) 2 with the
aid of tetrameric ruthenium catalyst 23 proceeded smoothly
at ambient temperature to deliver an ill-defined mixture of
stannylated products, which was not separable by flash
chromatography on silica or reverse-phase HPLC. Therefore,
the overall trans-selectivity of the double hydrostannation
reaction was only determined after protodestannation had
taken place.
Despite the ease of forging and subsequent elaboration of
the macrocyclic core, protodestannation of the alkenylstan-
nanes was particularly taxing. Treatment of the mixture of
stannanes with TFA, silica, TBAF or even in situ generated
HF, in both coordinating and non-coordinating media, led
either to no conversion or to decomposition. Confronted by
this impasse, we resorted to a different approach. Given that
most synthetic methodologies available for the downstream
functionalisation of alkenylstannanes rely on the reversible
transmetalation of tin to copper in polar solvents, we
considered protodestannation via the formation of an organo-
copper species in the presence of a tin scavenger and an
exogeneous proton source. After extensive experimentation
we found that employing a mixture of DMF/MeOH (10:1) in
the presence of copper(I) salt 24 at ambient temperature led
to successful protodestannation (Scheme 5 (iv)), furnishing
the desired (5E,21E) isomer (1) as the major stereoisomer
(crude HPLC ratio 78:22, (1):E/Z isomers). To our satisfac-
tion, the analytical and spectroscopic data of the synthetic
sample of 1 matched those of the natural product.
In summary, we have completed the first total synthesis of
the anti-malarial macrodiolide samroiyotmycin A (1) (9 steps
longest linear sequence, with an overall yield of 6%). This
convergent and scalable route showcases an initial asymmet-
ric alkylation of commercial 17, followed by a three-step
telescoped sequence to set the C(10)OH stereochemistry and
install the 1,3-oxazole unit, utilising an unprecedented
Schçllkopf-type condensation on enantioenriched b-lactones.
Forging the rigid macrocyclic core was achieved by an
efficient one-pot ACM–RCAM reaction using the latest
generation of alkyne metathesis catalysts, while the final
elaboration to the desired C2-symmetric macrodiolide was
possible via a delicate trans-hydrostannation–protodestanna-
tion sequence. These results demonstrate that, when com-
bined with contemporary hydrometallation chemistry, the
one-pot ACM–RCAM reaction can be a powerful manifold
for the assembly of complex molecular architectures. We
anticipate that this synthetic route will provide a solid base for
future exploration of other members of this family, and the
design of analogues with improved application profiles.
Scheme 5. Trans-hydrometallation and end game steps: (i) Unproduc-
tive 1,3-enyne hydrometallation; (ii) Protic-group-assisted trans-hydro-
stannation; (iii) Expected products from the double trans-hydrostanna-
tion of bis(enyne) 2 ; (iv) Reagents and Conditions: a) tetrameric
complex 23 (10 mol%), Bu3SnH, CH2Cl2, rt, 0.5 h; b) 24, DMF/MeOH
(10:1), rt, 2 h, 30% over two steps after preparative HPLC.
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Total Synthesis
E. Yiannakas, M. I. Grimes,
J. T. Whitelegge, A. Frstner,
A. N. Hulme* &&&&—&&&&
An Alkyne-Metathesis-Based Approach to
the Synthesis of the Anti-Malarial
Macrodiolide Samroiyotmycin A
Forging of the 20-membered macrocylic
core of samroiyotmycin A can be readily
achieved by combining a Mo-catalysed
one-pot alkyne cross-metathesis ring-
closing metathesis of bisalkyne building
blocks and Ru-catalysed hydrometallation
chemistry. These key transformations
have enabled the first total synthesis of
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